Global Blood Therapeutics Overview

Global Blood Therapeutics Cost of Revenue

Cost of Revenue analysis for GBT.

Quarterly Cost of Revenue

$1.41M

↑ 88.9% YoY

As of Jun 30, 2022

Annual Cost of Revenue (TTM)

$4.45M

↑ 58.66% YoY

Trailing 12 months ending Jun 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin